Your browser doesn't support javascript.
loading
[Cardiometabolic efficacy and toxicological evaluation of a pharmacological galanin receptor agonist]. / Kardiometabolicheskaia éffektivnost' i toksikologicheskaia kharakteristika farmakologicheskogo agonista retseptorov galanina.
Serebryakova, L I; Studneva, I M; Ovchinnikov, M V; Veselova, O M; Molokoedov, A S; Arzamastsev, E V; Afanasyeva, E Yu; Terekhova, O A; Sidorova, M V; Pisarenko, O I.
Afiliación
  • Serebryakova LI; National Medical Research Center for Cardiology, Moscow, Russia.
  • Studneva IM; National Medical Research Center for Cardiology, Moscow, Russia.
  • Ovchinnikov MV; National Medical Research Center for Cardiology, Moscow, Russia.
  • Veselova OM; National Medical Research Center for Cardiology, Moscow, Russia.
  • Molokoedov AS; National Medical Research Center for Cardiology, Moscow, Russia.
  • Arzamastsev EV; National Medical Research Center for Cardiology, Moscow, Russia.
  • Afanasyeva EY; National Medical Research Center for Cardiology, Moscow, Russia.
  • Terekhova OA; National Medical Research Center for Cardiology, Moscow, Russia.
  • Sidorova MV; National Medical Research Center for Cardiology, Moscow, Russia.
  • Pisarenko OI; National Medical Research Center for Cardiology, Moscow, Russia.
Biomed Khim ; 65(3): 231-238, 2019 Apr.
Article en Ru | MEDLINE | ID: mdl-31258147
The goal of this study was to examine effects of a novel galanin receptor agonist GalR1-3 [bAla14, His15]-galanine 2-15 (G), obtained by automatic solid-phase synthesis, on the metabolic state of the area at risk and the size of acute myocardial infarction (MI) in rats in vivo and evaluate its toxicity in BALB /c mice. In anesthetized rats, regional ischemia was simulated by coronary artery occlusion and then coronary blood flow was restored. The peptide G was administered intravenously (i.v.) with a bolus after a period of regional ischemia in the dose range of 0.25-3.0 mg/kg. The sizes of MI and the activities of creatine kinase-MB (СK-MB) and lactate dehydrogenase (LDH) in blood plasma were estimated. The effect of administration of the optimal dose of G (1.0 mg/kg) on myocardial content of adenine nucleotides (AN), phosphocreatine (PCr), creatine (Cr) and lactate was studied. I.v. administration of G to rats at a dose of 1.0 mg/kg slightly affected hemodynamic parameters, but reduced MI size by 40% and decreased plasma LDH and CK-MB activity by the end of reperfusion compared to control. These effects were accompanied by a significant improvement in energy state of area at risk (AAR) - an increase in myocardial content of ATP, åAN, PCr and åCr, and combined with a decrease in myocardial lactate level compared with the control. Toxicity of peptide G was studied with a single intraperitoneal injection of 0.5-3.0% solution of the peptide substance to mice. The absence of signs of intoxication and death of animals after G injection in the maximum possible dose did not allow determining the value of the average lethal dose. The results indicate therapeutic potential of the peptide G for preventing myocardial ischemia and reperfusion injury and feasibility for further study of its pharmacological properties and mechanisms of action.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Péptidos / Receptores de Galanina / Infarto del Miocardio Límite: Animals Idioma: Ru Revista: Biomed Khim Año: 2019 Tipo del documento: Article País de afiliación: Rusia Pais de publicación: Rusia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Péptidos / Receptores de Galanina / Infarto del Miocardio Límite: Animals Idioma: Ru Revista: Biomed Khim Año: 2019 Tipo del documento: Article País de afiliación: Rusia Pais de publicación: Rusia